Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Other Working Capital Changes (2015 - 2018)

Minerva Neurosciences' (NERV) quarterly Other Working Capital Changes came in at -$1086.0 in Q4 2018, up 100.0% YoY from -$543.01 in Q4 2017, and down 83.45% on a QoQ basis from -$592.0 in Q3 2018.

Analysis

Minerva Neurosciences (NERV) Other Working Capital Changes (2015 - 2018) Analysis & Trends

Minerva Neurosciences (NERV) has 2 years of Other Working Capital Changes data on file, last reported at $37.1 million in Q3 2017.

  • Quarterly Other Working Capital Changes rose 100.0% year-over-year to -$1086.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$888.0 (up 100.0% YoY) and the FY2018 annual result came in at -$888.0, down 102.97% from the prior year.
  • Other Working Capital Changes slipped to -$1086.0 in Q4 2018, from -$592.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $395.0 in Q1 2018 to a low of -$41.1 million in Q4 2017.
  • A 3-year average of -$5.1 million and a median of -$1825.0 in 2015 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 100.0% in 2018, down 100.0% in 2018.
  • Tracing NERV's Other Working Capital Changes over 3 years: stood at -$2565.0 in 2015, then plunged by 1604021.72% to -$41.1 million in 2017, then surged by 100.0% to -$1086.0 in 2018.
  • The last three Other Working Capital Changes figures came in at -$1086.0 (Q4 2018), -$592.0 (Q3 2018), and $395.0 (Q2 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Minerva Neurosciences 207.37 Mn 207.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -1,086.00
Dec 31, 2018 -1,086.00
Sep 30, 2018 -592.00
Sep 30, 2018 -592.00
Jun 30, 2018 395.00
Jun 30, 2018 395.00
Mar 31, 2018 395.00
Mar 31, 2018 395.00
Dec 31, 2017 -41.15 Mn
Dec 31, 2017 -41.15 Mn
Sep 30, 2017 37.08 Mn
Sep 30, 2017 37.08 Mn
Jun 30, 2017 3.57 Mn
Jun 30, 2017 3.57 Mn
Mar 31, 2017 530,298.00
Mar 31, 2017 530,298.00
Dec 31, 2016 -985,836.00
Dec 31, 2016 -985,836.00
Dec 31, 2015 1.21 Mn
Dec 31, 2015 1.21 Mn